The tax reform package within the One Big Beautiful Bill Act (OBBBA) continues to make its way through Congress, however, one proposed provision that imposes 'unfair foreign taxes' (section 899) has had a worldwide impact.
In a recent article, A&M Talent, Organization & People Solutions experts outline how organizations can modernize workflows, strengthen compliance and rebuild employee trust, all while boosting business agility.
Joining the Private Equity Performance Improvement Group, Mr. Golichowski helps clients unlock real estate portfolio value, accelerate value creation, and drive post-deal performance amidst a complex deal environment.
For decades, the United States has shouldered a disproportionate share of global pharmaceutical costs, accounting for 70% of global biopharma profits and over 80% of new drug launches. While this has helped drive significant medical innovation and supported the majority of global drug launches, it has also resulted in higher out-of-pocket costs for American patients.
